Spyridon Simantiris

689 total citations
24 papers, 465 citations indexed

About

Spyridon Simantiris is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Spyridon Simantiris has authored 24 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Spyridon Simantiris's work include Cardiovascular Disease and Adiposity (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Spyridon Simantiris is often cited by papers focused on Cardiovascular Disease and Adiposity (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Cardiac Imaging and Diagnostics (5 papers). Spyridon Simantiris collaborates with scholars based in Greece, United Kingdom and United States. Spyridon Simantiris's co-authors include Dimitris Tousoulis, Alexios S. Antonopoulos, Evangelos Oikonomou, Gerasimos Siasos, Konstantinos Tsioufis, Marinos Kosmopoulos, Panagiota K. Stampouloglou, Αnastassios Philippou, Konstantinos Mourouzis and Christodoulos Stefanadis and has published in prestigious journals such as Scientific Reports, European Heart Journal and Current Medicinal Chemistry.

In The Last Decade

Spyridon Simantiris

22 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Spyridon Simantiris Greece 9 199 164 90 80 70 24 465
Zhaofang Yin China 13 173 0.9× 80 0.5× 85 0.9× 54 0.7× 53 0.8× 29 403
Zulong Xie China 12 141 0.7× 336 2.0× 120 1.3× 43 0.5× 80 1.1× 31 608
Cristina Balla Italy 17 575 2.9× 135 0.8× 160 1.8× 78 1.0× 44 0.6× 65 838
Xiao‐Min Ren China 9 160 0.8× 113 0.7× 101 1.1× 73 0.9× 23 0.3× 12 337
Panagiota K. Stampouloglou Greece 9 159 0.8× 207 1.3× 61 0.7× 37 0.5× 57 0.8× 23 544
Keiichi Torimoto Japan 14 149 0.7× 163 1.0× 167 1.9× 29 0.4× 61 0.9× 58 777
Xiangbo An China 17 236 1.2× 390 2.4× 91 1.0× 35 0.4× 72 1.0× 28 740
Yinong Jiang China 13 342 1.7× 89 0.5× 111 1.2× 88 1.1× 47 0.7× 46 560

Countries citing papers authored by Spyridon Simantiris

Since Specialization
Citations

This map shows the geographic impact of Spyridon Simantiris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spyridon Simantiris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spyridon Simantiris more than expected).

Fields of papers citing papers by Spyridon Simantiris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spyridon Simantiris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spyridon Simantiris. The network helps show where Spyridon Simantiris may publish in the future.

Co-authorship network of co-authors of Spyridon Simantiris

This figure shows the co-authorship network connecting the top 25 collaborators of Spyridon Simantiris. A scholar is included among the top collaborators of Spyridon Simantiris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spyridon Simantiris. Spyridon Simantiris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skoumas, Ioannis, Ioannis Andrikou, Spyridon Simantiris, et al.. (2025). Lipoprotein(a) in familial dyslipidemias: The effect on cardiovascular prognosis in patients with familial hypercholesterolemia or familial combined hyperlipidemia. Nutrition Metabolism and Cardiovascular Diseases. 35(7). 103867–103867.
2.
Antonopoulos, Alexios, Ιoannis Panagiotopoulos, Konstantinos Spargias, et al.. (2025). Computed tomography-derived myocardial radiomics for detection of transthyretin amyloidosis in patients with severe aortic stenosis. Amyloid. 32(3). 226–237. 2 indexed citations
3.
Simantiris, Spyridon, et al.. (2024). Perivascular Fat: A Novel Risk Factor for Coronary Artery Disease. Diagnostics. 14(16). 1830–1830. 8 indexed citations
4.
Pamporis, Konstantinos, Paschalis Karakasis, Spyridon Simantiris, et al.. (2024). Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis. Clínica e Investigación en Arteriosclerosis (English Edition). 36(2). 86–100. 1 indexed citations
5.
Sagris, Μarios, Panayotis K. Vlachakis, Spyridon Simantiris, et al.. (2024). From a Cup of Tea to Cardiovascular Care: Vascular Mechanisms of Action. Life. 14(9). 1168–1168. 2 indexed citations
6.
Simantiris, Spyridon, Alexios S. Antonopoulos, Ioannis Skoumas, et al.. (2024). Lp(a) and vascular inflammation: data from perivascular fat attenuation index measurements. European Journal of Preventive Cardiology. 31(Supplement_1).
7.
Antonopoulos, Alexios S. & Spyridon Simantiris. (2023). Preventative Imaging with Coronary Computed Tomography Angiography. Current Cardiology Reports. 25(11). 1623–1632. 3 indexed citations
8.
Sagris, Μarios, Alexios S. Antonopoulos, Spyridon Simantiris, et al.. (2023). High-sensitivity Troponin (hs-Tn) for Cardiovascular RiskPrognostication: A Systematic Review and Meta-analysis. Current Medicinal Chemistry. 31(14). 1941–1953. 1 indexed citations
9.
Pamporis, Konstantinos, Paschalis Karakasis, Spyridon Simantiris, et al.. (2023). Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis. Clínica e Investigación en Arteriosclerosis. 36(2). 86–100. 1 indexed citations
10.
Antonopoulos, Alexios S., Spyridon Simantiris, Νικόλαος Κούμαλλος, et al.. (2023). Interleukin-6 Signaling in Atherosclerosis: From Molecular MechanismsTo Clinical Outcomes. Current Topics in Medicinal Chemistry. 23(22). 2172–2183. 4 indexed citations
11.
Simantiris, Spyridon, Alexios S. Antonopoulos, Panagiotis Theofilis, et al.. (2023). Oxidative Stress Biomarkers in Coronary Artery Disease. Current Topics in Medicinal Chemistry. 23(22). 2158–2171. 9 indexed citations
12.
Antonopoulos, Alexios S., Spyridon Simantiris, Νικόλαος Κούμαλλος, et al.. (2023). Stem Cell-based Therapies in Cardiovascular Diseases: From Pathophysiologyto Clinical Outcomes. Current Pharmaceutical Design. 29(35). 2795–2801. 2 indexed citations
13.
Simantiris, Spyridon, Alexios S. Antonopoulos, Georgios Benetos, et al.. (2022). Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease. Journal of clinical lipidology. 17(1). 55–63. 26 indexed citations
14.
Antonopoulos, Alexios S., Spyridon Simantiris, Evangelos K. Oikonomou, et al.. (2021). Biomarkers of Vascular Inflammation for Cardiovascular Risk Prognostication. JACC. Cardiovascular imaging. 15(3). 460–471. 58 indexed citations
15.
Antonopoulos, Alexios S., Spyridon Simantiris, George Lazaros, et al.. (2021). Machine learning of native T1 mapping radiomics for classification of hypertrophic cardiomyopathy phenotypes. Scientific Reports. 11(1). 23596–23596. 39 indexed citations
16.
17.
Lazaros, George, Alexios S. Antonopoulos, Panagiotis Skendros, et al.. (2020). Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study. International Journal of Cardiology. 311. 77–82. 22 indexed citations
18.
Simantiris, Spyridon, et al.. (2019). The role of kisspeptin system in cancer biology. Critical Reviews in Oncology/Hematology. 142. 130–140. 18 indexed citations
19.
Antonopoulos, Alexios S., Evangelos Oikonomou, Νικόλαος Παπαγεωργίου, et al.. (2019). Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes. Journal of Molecular and Cellular Cardiology. 138. 110–114. 21 indexed citations
20.
Siasos, Gerasimos, Vasiliki Tsigkou, Marinos Kosmopoulos, et al.. (2018). Mitochondria and cardiovascular diseases—from pathophysiology to treatment. Annals of Translational Medicine. 6(12). 256–256. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaofang Yin Breakdown of academic impact, for papers by Zulong Xie Breakdown of academic impact, for papers by Cristina Balla Breakdown of academic impact, for papers by Xiao‐Min Ren Breakdown of academic impact, for papers by Panagiota K. Stampouloglou Breakdown of academic impact, for papers by Keiichi Torimoto Breakdown of academic impact, for papers by Xiangbo An Breakdown of academic impact, for papers by Yinong Jiang
Rankless by CCL
2026